Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.
Slama J, Runnebaum IB, Scambia G, Angeles MA, Bahrehmand K, Kommoss S, Fagotti A, Narducci F, Matylevich O, Holly J, Martinelli F, Koual M, Kopetskyi V, El-Balat A, Corrado G, Căpîlna ME, Schröder W, Novàk Z, Shushkevich A, Fricová L, Cibula D. Slama J, et al. Among authors: corrado g. Am J Obstet Gynecol. 2023 Apr;228(4):443.e1-443.e10. doi: 10.1016/j.ajog.2022.11.1295. Epub 2022 Nov 23. Am J Obstet Gynecol. 2023. PMID: 36427596
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer.
Ferrandina G, Ludovisi M, Corrado G, Carone V, Petrillo M, Scambia G. Ferrandina G, et al. Among authors: corrado g. Gynecol Oncol. 2008 May;109(2):187-93. doi: 10.1016/j.ygyno.2008.01.039. Epub 2008 Mar 17. Gynecol Oncol. 2008. PMID: 18343487 Clinical Trial.
437 results